Physician profile
Brett A Schultz
NPI 1922217884
$1,511.74
in general payments reported to CMS, 2019-2025
17 companies · $478 in 2025
The $478 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $88.15 · 2021: $17.52 · 2022: $351 · 2023: $106 · 2024: $111 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $390.32 | 2022-2025 | Truclear, Ligasure, Situate |
| Coopersurgical, INC. | $310.73 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $164.09 | 2024-2025 | Acessa Provu System, Aptima |
| Caldera Medical, INC | $129.63 | 2022 | |
| Baxter Healthcare | $115.11 | 2019-2024 | Tisseel |
| Astellas Pharma US INC | $94.11 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $72.91 | 2019-2024 | |
| Exeltis, USA INC. | $39.83 | 2023-2024 | Slynd |
| Organon LLC | $35.94 | 2021-2025 | Nexplanon |
| Sage Therapeutics, LLC | $24.05 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $24.05 | 2025 | Qelbree |
| Mayne Pharma Commercial LLC | $21.63 | 2025 | |
| Pfizer INC. | $20.50 | 2023 | |
| Amag Pharmaceuticals, INC. | $18.29 | 2020 | |
| Abbvie INC. | $17.09 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.84 | 2019 | |
| Therapeuticsmd, INC. | $16.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.